XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue, net $ 2,874 $ 1,965 $ 8,139 $ 26,068
Operating expenses:        
Cost of revenue 141 0 200 2,000
Research and development 5,385 2,239 13,262 7,352
General and administrative 3,974 1,948 10,266 6,145
Acquired in-process research and development 0 0 17,663 0
Total operating expenses 9,500 4,187 41,391 15,497
(Loss) income from operations (6,626) (2,222) (33,252) 10,571
Other (expense) income:        
Loss on extinguishment of debt 0 0 0 (16,096)
Interest expense related to amortization of debt issuance costs and discount 0 0 0 (150)
Interest expense on principal (124) (6) (165) (221)
Fair value adjustment related to derivative and warrant liability 22 332 295 (92)
Interest and other (expense) income, net 79 137 (152) 136
Total other (expense) income (23) 463 (22) (16,423)
Loss before income taxes (6,649) (1,759) (33,274) (5,852)
Income tax benefit 33 0 752 0
Net income (loss) (6,616) (1,759) (32,522) (5,852)
Deemed dividend 0 0 0 (54,342)
Net loss attributable to common stockholders $ (6,616) $ (1,759) $ (32,522) $ (60,194)
Basic and diluted net loss per share of common stock:        
Net loss attributable to common stockholders (in dollars per share) $ (0.19) $ (0.05) $ (0.94) $ (2.16)
Weighted average number of shares of common stock outstanding:        
Basic and diluted (in shares) 34,494,702 35,217,953 34,482,791 27,904,711